These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29667546)

  • 1. Seminal suPAR Levels as Marker of Abacterial Male Accessory Gland Inflammation in Hypogonadism.
    Milardi D; Grande G; Autilio C; Mancini F; De Marinis L; Marana R; Zuppi C; Urbani A; Pontecorvi A; Baroni S
    Protein Pept Lett; 2018; 25(5):478-482. PubMed ID: 29667546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble urokinase-type plasminogen activator receptor as a putative marker of male accessory gland inflammation.
    Autilio C; Morelli R; Milardi D; Grande G; Marana R; Pontecorvi A; Zuppi C; Baroni S
    Andrology; 2015 Nov; 3(6):1054-61. PubMed ID: 26384478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel biomarkers of androgen deficiency from seminal plasma profiling using high-resolution mass spectrometry.
    Milardi D; Grande G; Vincenzoni F; Giampietro A; Messana I; Castagnola M; Marana R; De Marinis L; Pontecorvi A
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2813-20. PubMed ID: 24796927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of seminal markers of male accessory gland inflammation: From molecules to proteome.
    Grande G; Milardi D; Baroni S; Luca G; Pontecorvi A
    Am J Reprod Immunol; 2018 Aug; 80(2):e12992. PubMed ID: 29992660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal treatment with transdermal testosterone in patients with male accessory gland inflammation (MAGI): Effects on sperm parameters.
    La Vignera S; Condorelli RA; Mongioi LM; Vitale SG; Russo GI; Laganà AS; Calogero AE
    Andrologia; 2017 Oct; 49(8):. PubMed ID: 27882582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
    Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL
    J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untreated Psoriasis Impairs Male Fertility: A Case-Control Study.
    Caldarola G; Milardi D; Grande G; Quercia A; Baroni S; Morelli R; Marana R; Pontecorvi A; De Simone C; Peris K
    Dermatology; 2017; 233(2-3):170-174. PubMed ID: 28595175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why Do We Need New Markers for Male Hypogonadism and How Seminal Proteomics Might Solve the Problem?
    Grande G; Milardi D; Baroni S; Urbani A; Pontecorvi A
    Protein Pept Lett; 2020; 27(12):1186-1191. PubMed ID: 32370701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality.
    Zimmermann HW; Reuken PA; Koch A; Bartneck M; Adams DH; Trautwein C; Stallmach A; Tacke F; Bruns T
    J Intern Med; 2013 Jul; 274(1):86-100. PubMed ID: 23432143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significantly increased concentration of soluble urokinase-type plasminogen activator receptor in the blood of patients with pelvic inflammatory disease.
    Yeh YH; Wang PH; Lin LY; Tee YT; Chou MC; Yang SF; Tsai HT
    Clin Chim Acta; 2013 Jan; 415():138-44. PubMed ID: 23117033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia.
    Erkut N; Menteşe A; Özbaş HM; Ermantaş N; Sümer A; Örem A; Sönmez M
    Turk J Haematol; 2016 Jun; 33(2):135-40. PubMed ID: 26376588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer.
    Wach S; Al-Janabi O; Weigelt K; Fischer K; Greither T; Marcou M; Theil G; Nolte E; Holzhausen HJ; Stöhr R; Huppert V; Hartmann A; Fornara P; Wullich B; Taubert H
    Int J Cancer; 2015 Sep; 137(6):1406-16. PubMed ID: 25754273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone supplementation does not worsen lower urinary tract symptoms.
    Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
    J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic significance of suPAR in traumatic brain injury.
    Yu L; Wu X; Wang H; Long D; Yang J; Zhang Y
    Neurol India; 2014; 62(5):498-502. PubMed ID: 25387618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
    Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
    BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Age-related androgen deficiency and benign prostatic hyperplasia: how to improve the rehabilitation of patients after transurethral surgery?].
    Martov AG; Ergakov DV
    Urologiia; 2016 Dec; (6):110-117. PubMed ID: 28248054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
    Mekonnen G; Corban MT; Hung OY; Eshtehardi P; Eapen DJ; Al-Kassem H; Rasoul-Arzrumly E; Gogas BD; McDaniel MC; Pielak T; Thorball CW; Sperling L; Quyyumi AA; Samady H
    Atherosclerosis; 2015 Mar; 239(1):55-60. PubMed ID: 25574858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.